A genetically modulated Toll-like-receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome

Rehan Khan,Weizhen Ji,Jeisac Guzman-Rivera,Abhilasha Madhvi,Tracy Andrews,Benjamin Richlin,Christian Suarez,Sunanda Gaur,William Cuddy,Aalok R. Singh,Hulya Bukulmez,David Kaelber,Yukiko Kimura,Usha Ganapathi,Ioannis E. Michailidis,Rahul Ukey,Sandra Moroso-Fela,John K. Kuster,Myriam Casseus,Jason Roy,Lawrence C. Kleinman,Daniel B. Horton,Saquib A. Lakhani,Maria Laura Gennaro
DOI: https://doi.org/10.1101/2024.02.02.24301686
2024-02-05
Abstract:Dysregulated innate immune responses contribute to multisystem inflammatory syndrome in children (MIS-C), characterized by gastrointestinal, mucocutaneous, and/or cardiovascular injury occurring weeks after SARS-CoV-2 exposure. To investigate innate immune functions in MIS-C, we stimulated peripheral blood cells from MIS-C patients with agonists of Toll-like receptors (TLR), key innate immune response initiators. We found severely dampened cytokine responses and elevated gene expression of negative regulators of TLR signaling. Increased plasma levels of zonulin, a gut leakage marker, were also detected. These effects were also observed in children enrolled months after MIS-C recovery. Moreover, cells from MIS-C children carrying rare genetic variants of lysosomal trafficking regulator ( ) were less refractory to TLR stimulation and exhibited lysosomal and mitochondrial abnormalities with altered energy metabolism. Our results strongly suggest that MIS-C hyperinflammation and/or excessive or prolonged stimulation with gut-originated TLR ligands drive immune cells to a lasting refractory state. TLR hyporesponsiveness is likely beneficial, as suggested by excess lymphopenia among rare variant carriers. Our findings point to cellular mechanisms underlying TLR hyporesponsiveness; identify genetic determinants that may explain the MIS-C clinical spectrum; suggest potential associations between innate refractory states and long COVID; and highlight the need to monitor long-term consequences of MIS-C.
Infectious Diseases (except HIV/AIDS)
What problem does this paper attempt to address?